NCT07260175 2026-02-23adIVOInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestPhase 2 Recruiting40 enrolled
NCT07282262 2025-12-15An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.Peking Union Medical College HospitalPhase 2 Recruiting300 enrolled